Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

North Carolina Senate Delays Vote On Latest Version Of Sex Education Bill
The North Carolina Senate has delayed until Wednesday its vote on a bill (S. 221) that would require public school systems in the state to offer a sex education curriculum that includes information on both abstinence and prevention of pregnancy and sexually transmitted infections, the Fayetteville Observer reports. Currently, most public schools in the state teach abstinence-only sex education (Fayetteville Observer, 6/11).The bill, which a state Senate committee approved earlier in the week, made major changes to a state House version (H.B. 88) that conservative and liberals in the chamber approved as a compromise measure. The House bill would have required parents to choose from three sex education options: abstinence-only; an abstinence-based program with information on pregnancy and STI prevention; or no sex education. The third option would be the default if parents did not make a selection (Woolverton, Fayetteville Observer, 6/11).The Senate version of the bill was designed to merge the abstinence-only and the abstinence-based comprehensive options of the House bill. Parents would be able to request that their children not receive the comprehensive portions of the lessons.According to the Observer, some lawmakers objected to the idea in the House bill that students would receive no sex education if their parents failed to make a selection. In addition, some school officials voiced concern that the House version would require more teachers and classroom space to meet the requirements for three separate options (Fayetteville Observer, 6/11).
generic viagra online
Delaware HIV/AIDS Organization Forced To Close After 28 Years
A Delaware-based organization that has provided HIV prevention, outreach, education and other services for the past 28 years will be closing due to lack of funding, the Bethany Beach Wave reports. The Sussex County AIDS Committee (SCAC) also provided financial assistance, transportation services and assistance with medical appointments to people living with HIV/AIDS from as far as Philadelphia, according to the Wave. SCAC was funded by both private and government funding. "We just ran out of money," Curt Barrows, president of the SCAC board, said. CAMP Rehoboth, another local organization, said it will step in to assist SCAC clients (Shockley, Bethany Beach Wave, 6/18).
News of the day
New DVD Helps Doctors Managing Difficult Issues
To support doctors who are confronted with challenging issues in medical practice, the Royal Australian College of General Practitioners (RACGP) and the Medical Practitioners Board of Victoria have developed a DVD that provides doctors with tips on managing difficult situations while maintaining their legal and ethical obligations.
Health Insurance

Revance Therapeutics Announces Efficacy Of Topical Botulinum Toxin Type A For The Treatment Of Facial Wrinkles

Revance Therapeutics, Inc. ("Revance") announces that RT001, a topical botulinum toxin type A, under investigation for the treatment of crow"s feet wrinkles, demonstrated efficacy and safety in a US Phase 2b clinical study. The randomized, double-blind, parallel-group, dose-finding study showed efficacy versus placebo at primary and multiple secondary endpoints. This is the most recent Phase 2 study to demonstrate the efficacy of RT001 and the results are consistent with earlier Phase 2 studies conducted in the US and internationally. More than 200 patients have been treated with RT001 and it has been safe and well tolerated. "The benefits of RT001 are clear; patients achieve meaningful aesthetic results with a simple, painless procedure" said Richard Glogau, MD, Clinical Professor of Dermatology at University of California, San Francisco and principal investigator for the study, "The superficial muscles in the crow"s feet area can be relatively difficult to inject; this treatment will allow physicians to obtain a more consistent result while maintaining patients" natural expressions". Fredric Brandt, MD, who also participated in the study agrees, "RT001 represents a natural evolution in the treatment regimen which will appeal to a whole new segment of patients who want the cosmetic benefit but are unwilling to tolerate the discomfort and bruising caused by multiple injections". "We are very pleased with our progress and the data generated from our Phase 2 clinical program," commented Dan Browne, President and CEO of Revance, "It represents an important milestone for the company as we proceed to our End of Phase 2 meeting with the FDA later this year. I want to thank all the US and international Phase 2 Investigators and their clinical research teams for their efforts to achieve this milestone." About RT001 RT001, Botulinum Toxin Type A Topical Gel, an investigational product, is designed to reduce crow"s feet wrinkles by temporarily relaxing the muscles around the eye. Unlike other procedures that require several injections in the sensitive periorbital area, RT001 gel is simply applied by the physician and then wiped off after the procedure. Revance"s goal is to expand the market beyond other injectable treatments like Botox® Cosmetic, which despite their popularity, have only captured about 10% of the market. The Company believes that offering a safe, efficacious and painless procedure will appeal to the 9 out of 10 consumers who have considered treatment but are uncomfortable with the pain and bruising associated with injectables. RT001 is currently being studied for the treatment of lateral canthal lines (crow"s feet) and hyperhidrosis (excessive sweating). Revance Therapeutics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009